Breakthrough

Join the conversation to advance life sciences R&D with innovation, digital transformation, and enterprise automation.

 

September 21st & 22nd, 2021

About Breakthrough 2021

ArisGlobal’s Breakthrough 2021 is a virtual event designed to bring together members of the life sciences industry to discuss innovation and digital transformation trends within R&D.  This year’s event will feature sessions and keynotes delivered by leading voices from the industry, with the goal of sharing best practices, experiences, and ideas. 

Event Details

September

21 – 22, 2021

A fully virtual event

Live

and on-demand sessions
R

Free to register and attend

LifeSphere Intake and Triage

Highlights

  • Hear from leading voices in life sciences across two days of thought-provoking conversations
  • Share ideas with peers and interact with experts
  • Learn directly from ArisGlobal customers as they share R&D technology best practices and successes
  • Access an on-demand library of content
  • Complimentary attendance for all

Who Should Attend

Breakthrough 2021 is designed for life sciences professionals across Clinical Operations, Clinical Data Management, Regulatory Affairs, Medical Affairs, Drug Safety, IT, and Procurement.

Medical Affairs - LifeSphere Medical Affairs

Register Here


BREAKTHROUGH

Last Year’s Attendees

“This is a great opportunity to connect and build a bigger partnership with life science peers and regulators”

Johnson & Johnson

“A tremendous event to learn from industry thought leaders and move life sciences forward”

Boehringer Ingleheim 

Highlights from Last Year

Previous Speakers and Panelists 

Rob Scott, MD

Dr. Rob Scott

Former Chief Medical Officer and Head of Development,
AbbVie

Hans van Leeuwen

Head of Regulatory Operations, Europe,
Astellas

Georgia Papathomas, PhD

Former SVP, Global Head of Data Sciences,
Johnson & Johnson

Vita Cassese

Dr. Rob Scott

CEO Mardon Management Advisors Former CIO, Worldwide Pharmaceuticals Group,
Pfizer

Juergen Schmider, MD, PHD

President, Drug and Device Vigilance Consulting Former VP, Safety Evaluation and Reporting,
Pfizer

Paul Chew, MD

President, 1Rx Digipharm Advisory Former CMO, Omada Health Former SVP, Global CMO and Head of US R&D, Sanofi

Frits Stulp

Dr. Rob Scott

Managing Director,
Iperion

Steve Gens

Managing Partner,
Gens & Associates

Sankesh Abbhi

Sankesh Abbhi

President and CEO, ArisGlobal

Vita Cassese

CEO Mardon Management Advisors
Former CIO, Worldwide Pharmaceuticals Group, Pfizer

Juergen Schmider, MD, PHD

President, Drug and Device Vigilance Consulting

Former VP, Safety Evaluation and Reporting, Pfizer

BREAKTHROUGH by the numbers

50+

Top Biopharmas Represented

100’s

Life Science Leaders Attending

25+

Inspiring Speakers